Pear Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 218

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Pear Therapeutics General Information

Description

Pear Therapeutics Inc is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDTs), which use software to treat diseases directly. The company's vision is to advance healthcare through the widespread use of PDTs and to be the one-stop shop for PDTs offered by Pear and other organizations that may choose to make their products available to patients, providers, and payors via its commercial platform, known as PearConnect. It features four distinct system components, consisting of PDTs for patient use, the PearMD Clinician Dashboard, an end-to-end patient service center, and a data analytics system configured to aggregate patient engagement, adherence, and clinical outcome data.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Corporate Office
  • 200 State Street
  • Boston, MA 02109
  • United States

Pear Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pear Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Bankruptcy: Admin/Reorg 07-Apr-2023 Completed Bankruptcy: Admin/Reorg
12. PIPE 03-Dec-2021 00000 00000 00.00 Completed Generating Revenue
11. Reverse Merger 03-Dec-2021 00000 00000 00.000 Completed Generating Revenue
10. Later Stage VC (Series D) 02-Mar-2021 00000 00000 Completed Generating Revenue
9. Grant 30-Sep-2020 000.00 00000 Completed Generating Revenue
8. Mezzanine 07-Jul-2020 0000 00000 Completed Generating Revenue
7. Grant 30-Sep-2019 00000 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 04-Jan-2019 0000 00000 00000 Completed Generating Revenue
5. Early Stage VC (Series B) 28-Dec-2017 $50M $75M 00000 Completed Generating Revenue
4. Grant 01-Jul-2017 $334K $25M Completed Generating Revenue
To view Pear Therapeutics’s complete valuation and funding history, request access »

Pear Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series A 24,002,981 $0.000100 8% $0.92 $0.92 1x $0.92 34.95%
To view Pear Therapeutics’s complete cap table history, request access »

Pear Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Pear Therapeutics Inc is a commercial-stage healthcare company pioneering a new class of software-based medicines, somet
Other Healthcare Technology Systems
Boston, MA
218 As of 2023
00000
0000000000.

000000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
00000 0000000000 000
Atlanta, GA
0000 As of 0000
00000
0000000000

000000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
00000 0000000000 000
New York, NY
000 As of 0000
00000
0.00 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pear Therapeutics Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sharecare Formerly PE-Backed Atlanta, GA 0000 00000 0000000000
Rightway Venture Capital-Backed New York, NY 000 00000 00000000000 00000
Wellframe Private Equity-Backed Boston, MA 000 0000 000000000000 0000
Geneia Corporation Harrisburg, PA
Akili Interactive Formerly VC-backed Boston, MA 00 00000 000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Pear Therapeutics Patents

Pear Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4176448-A1 Systems, methods, and devices for generating and administering digital therapeutic placebos and shams Pending 02-Jul-2020 000000000
CA-3179823-A1 Systems, methods, and devices for generating and administering digital therapeutic placebos and shams Pending 02-Jul-2020 000000000
US-20200372990-A1 Systems and methods for visualizing and modifying treatment of a patient utilizing a digital therapeutic Inactive 22-May-2019 000000000 0
EP-3963601-A1 System and methods for clinical curation of crowdsourced data Pending 30-Apr-2019 000000000
AU-2020266572-A1 System and methods for clinical curation of crowdsourced data Inactive 30-Apr-2019 G16H40/67
To view Pear Therapeutics’s complete patent history, request access »

Pear Therapeutics Executive Team (19)

Name Title Board Seat Contact Info
Christopher Guiffre JD Assistant Secretary, Administration & Chief Executive Officer
Yuri Maricich MD Chief Medical Officer and Head of Development
Julia Strandberg Chief Commercial Officer
Erin Brenner Chief Product Development Officer
Ellen Snow Chief Accounting Officer, Accounting & Vice President
You’re viewing 5 of 19 executive team members. Get the full list »

Pear Therapeutics Board Members (21)

Name Representing Role Since
Alison Bauerlein Self Board Member 000 0000
Andrew Schwab 5AM Ventures Board Member 000 0000
Corey McCann Ph.D Pear Therapeutics Chief Executive Officer, President, and board Member 000 0000
Kirthiga Reddy SoftBank Investment Advisers Board Member 000 0000
Nancy Schlichting Self Board Member 000 0000
You’re viewing 5 of 21 board members. Get the full list »

Pear Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pear Therapeutics Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Waypoint Health Innovations (Digital Therapeutic Assets) 16-Dec-2021 000000000 Other Healthcare Technology Systems 00000 000
Thimble Point Acquisition 03-Dec-2021 0000000000 Special Purpose Acquisition Company (SPAC) 00000 000
Firsthand Technology (VR tech for pain treatment) 07-Jan-2020 Corporate Asset Purchase Buildings and Property 00000 000
To view Pear Therapeutics’s complete investments and acquisitions history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »